National Repository of Grey Literature 2 records found  Search took 0.00 seconds. 
Effectiveness of venlafaxine in the treatment of depression
Dagisová, Ruta ; Hrdina, Radomír (advisor) ; Herink, Josef (referee)
5 ABSTRACT The objective of this analysis was to determine the efficacy and acceptability of venlafaxine in comparison with that of placebo and other antidepressants in the treatment of major depression by pooling short-term clinical trials with in-patients and out-patients. Randomised controlled trials were identified by searching of databases Pub-Med Medline and Embase. In metaanalysis were combined 15 trials, three of them were controlled by placebo and 12 by reference drugs. Clinical trials had to use either HAM-D, MADRS or the CGI-I scales as their primary outcome measure and reported response rates, defined as 50% or greater decrease in depression severity (according to the HAM-D and MADRS) or score 1 (very improved) or 2 (improved) (according to the CGI-I scale) from baseline to endpoint. Acceptability to patients was assessed by comparison of total drop-outs in two arms of the trials. For each efficacy variable (e.g. rating scales HAM-D, MADRS and CGI) and for subgroups of placebo and reference drugs were conducted partial analysis. The statistical analysis of data-sets was performed with statistical program MIX, version 1.54. To estimate size-effect was calculated parameter relative risk (RR) and to determine its reliability was 95% confidence interval was estimated. To compare response rates among...
Effectiveness of venlafaxine in the treatment of depression
Dagisová, Ruta ; Hrdina, Radomír (advisor) ; Herink, Josef (referee)
5 ABSTRACT The objective of this analysis was to determine the efficacy and acceptability of venlafaxine in comparison with that of placebo and other antidepressants in the treatment of major depression by pooling short-term clinical trials with in-patients and out-patients. Randomised controlled trials were identified by searching of databases Pub-Med Medline and Embase. In metaanalysis were combined 15 trials, three of them were controlled by placebo and 12 by reference drugs. Clinical trials had to use either HAM-D, MADRS or the CGI-I scales as their primary outcome measure and reported response rates, defined as 50% or greater decrease in depression severity (according to the HAM-D and MADRS) or score 1 (very improved) or 2 (improved) (according to the CGI-I scale) from baseline to endpoint. Acceptability to patients was assessed by comparison of total drop-outs in two arms of the trials. For each efficacy variable (e.g. rating scales HAM-D, MADRS and CGI) and for subgroups of placebo and reference drugs were conducted partial analysis. The statistical analysis of data-sets was performed with statistical program MIX, version 1.54. To estimate size-effect was calculated parameter relative risk (RR) and to determine its reliability was 95% confidence interval was estimated. To compare response rates among...

Interested in being notified about new results for this query?
Subscribe to the RSS feed.